公开(公告)号：US12128080B2

公开(公告)日：2024-10-29

申请号：US17254373

申请日：2019-06-17

申请人： NSC PHARMA GMBH & CO. KG

发明人： Rolf Daniels ,  Francis Karnau Mwiiri

IPC分类号： A61K36/185 ,  A61K9/107 ,  A61K9/12 ,  A61K9/70 ,  A61K31/015 ,  A61K31/047 ,  A61K31/19 ,  A61K31/215 ,  A61K47/24 ,  A61K47/32 ,  A61K47/44 ,  A61P17/02 ,  D01D5/00 ,  D04H1/728

CPC分类号： A61K36/185 ,  A61K9/1075 ,  A61K9/122 ,  A61K9/7015 ,  A61K31/015 ,  A61K31/047 ,  A61K31/19 ,  A61K31/215 ,  A61K47/24 ,  A61K47/32 ,  A61K47/44 ,  A61P17/02 ,  D01D5/0007 ,  D04H1/728 ,  D10B2509/022

摘要： The present invention relates to compositions based on nanodispersions which are preferably further processed to electrospun fibers comprising such nanodispersions. The nanodispersions may optionally contain birch bark extract. The electrospun fibers can be used in particular for the treatment of wounds. For this purpose the compositions containing electrospun fibers are preferably applied as such or in a spray or a foam.

公开(公告)号：US20240325344A1

公开(公告)日：2024-10-03

申请号：US18625194

申请日：2024-04-02

申请人： David Alan Heldreth, JR.

发明人： David Alan Heldreth, JR.

IPC分类号： A61K31/352 ,  A61K31/015 ,  A61K31/05 ,  A61K31/135 ,  A61K31/164 ,  A61K31/165 ,  A61K31/404 ,  A61K31/4045 ,  A61K31/473 ,  A61K31/4741 ,  A61K31/48 ,  A61K31/675 ,  A61K31/704 ,  A61K33/06 ,  A61K33/30 ,  A61K36/68 ,  A61K36/77

CPC分类号： A61K31/352 ,  A61K31/015 ,  A61K31/05 ,  A61K31/135 ,  A61K31/164 ,  A61K31/165 ,  A61K31/404 ,  A61K31/4045 ,  A61K31/473 ,  A61K31/4741 ,  A61K31/48 ,  A61K31/675 ,  A61K31/704 ,  A61K33/06 ,  A61K33/30 ,  A61K36/68 ,  A61K36/77

摘要： The invention involves the use of formulations of allosteric modulators of primarily 5ht2/tht1, CB1 and GLP-1 serotonin transporter, but also those of: 5ht1a/b/c/d, 5ht2a/b/c, 5ht3, 5ht4, 5ht7 and other receptors, in combination with phenethylamines, tryptamines, ibogaloids and other compounds; to treat or reduce symptoms of ingestion of drugs such as Cannabis or 5ht2a agonists. The method of delivery/formulation selected from: Beverage (soda, water, tea, coffee, or other), Candy (gum, gummy, chocolate, hard candy, taffy, or other), Food, smoking, vaping, e-cigarette, vape-pen, bong, vaporizer, tab, geltab, blotter, sublingual strip.

公开(公告)号：US20240325342A1

公开(公告)日：2024-10-03

申请号：US18625181

申请日：2024-04-02

申请人： David Alan Heldreth, JR.

发明人： David Alan Heldreth, JR.

IPC分类号： A61K31/352 ,  A61K31/015 ,  A61K31/05 ,  A61K31/135 ,  A61K31/164 ,  A61K31/165 ,  A61K31/404 ,  A61K31/4045 ,  A61K31/473 ,  A61K31/4741 ,  A61K31/48 ,  A61K31/675 ,  A61K31/704 ,  A61K33/06 ,  A61K33/30 ,  A61K36/68 ,  A61K36/77

CPC分类号： A61K31/352 ,  A61K31/015 ,  A61K31/05 ,  A61K31/135 ,  A61K31/164 ,  A61K31/165 ,  A61K31/404 ,  A61K31/4045 ,  A61K31/473 ,  A61K31/4741 ,  A61K31/48 ,  A61K31/675 ,  A61K31/704 ,  A61K33/06 ,  A61K33/30 ,  A61K36/68 ,  A61K36/77

摘要： The invention involves the use of formulations of allosteric modulators of primarily 5ht2/5ht1, opiate or SERT serotonin transporter, but also those of: 5ht1a/b/c/d, 5ht2a/b/c, 5ht3, 5ht4, 5ht7, dopamine, GLP, and other receptors/systems, in combination with phenethylamines, tryptamines, ibogaloids as well as vaccines, antibodies and other compounds; to treat opiate dependency (addiction). Wherein opiate means, any opiate compound/mixture/drug, including, but not limited to synthetic, semisynthetic, natural, such as but not limited to opium, morphine, heroin, codeine, oxycodone, fentanyl, methadone, or other.

公开(公告)号：US20240316133A1

公开(公告)日：2024-09-26

申请号：US18635597

申请日：2024-04-15

申请人： Ecofibre USA Inc.

发明人： Alexandra M. Capano ,  Pradeep Singh Tanwar ,  Alex Nance

IPC分类号： A61K36/185 ,  A61K31/01 ,  A61K31/015 ,  A61K31/045 ,  A61K31/05 ,  A61K31/198 ,  A61K31/216 ,  A61K31/282 ,  A61K31/337 ,  A61K31/352 ,  A61K31/355 ,  A61K31/395 ,  A61K31/4745 ,  A61K31/513 ,  A61K31/519 ,  A61K31/675 ,  A61K31/704 ,  A61K31/7048 ,  A61K31/7068 ,  A61K33/243 ,  A61K39/395 ,  A61P35/00

CPC分类号： A61K36/185 ,  A61K31/01 ,  A61K31/015 ,  A61K31/045 ,  A61K31/05 ,  A61K31/198 ,  A61K31/216 ,  A61K31/282 ,  A61K31/337 ,  A61K31/352 ,  A61K31/355 ,  A61K31/4745 ,  A61K31/513 ,  A61K31/519 ,  A61K31/5545 ,  A61K31/675 ,  A61K31/704 ,  A61K31/7048 ,  A61K31/7068 ,  A61K33/243 ,  A61K39/3955 ,  A61P35/00

摘要： Methods for treating ovarian cancer comprising: administering to a patient and effective amount of a cannabis extract comprising CBD wherein preferably the cannabis extract is administered via a mucosal formulation.

公开(公告)号：US20240293354A1

公开(公告)日：2024-09-05

申请号：US18280930

申请日：2022-03-25

申请人： LIBI PHARM LTD

发明人： Raziel RONEN ,  Dobroslav MELAMED

IPC分类号： A61K31/343 ,  A61K31/015 ,  A61K31/045 ,  A61K31/05 ,  A61K31/085 ,  A61K31/11 ,  A61K31/122 ,  A61K31/22 ,  A61K33/04 ,  A61K33/30 ,  A61K36/15 ,  A61K36/185 ,  A61K36/53 ,  A61K36/534 ,  A61K36/537 ,  A61K36/61 ,  A61K45/06 ,  A61P37/02

CPC分类号： A61K31/343 ,  A61K31/015 ,  A61K31/045 ,  A61K31/05 ,  A61K31/085 ,  A61K31/11 ,  A61K31/122 ,  A61K31/22 ,  A61K33/04 ,  A61K33/30 ,  A61K36/15 ,  A61K36/185 ,  A61K36/53 ,  A61K36/534 ,  A61K36/537 ,  A61K36/61 ,  A61K45/06 ,  A61P37/02

摘要： The invention relates to a method and a composition for treating or preventing an inflammatory, autoimmune and/or Coronavirus disease and/or symptom. In some embodiments, the-invention relates to a method or a composition for treating or preventing a Coronavirus disease-19 (COVID-19) as well as preventing and curing long term COVID-19 side effects. The composition is a herbal mineral composition or includes the active ingredients that may be found in herbs together with a mineral.

公开(公告)号：US20240226238A1

公开(公告)日：2024-07-11

申请号：US18396828

申请日：2023-12-27

申请人： INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) ,  UNIVERSITE PAUL SABATIER TOULOUSE III ,  CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE

发明人： Philippe VALET ,  Cedric Dray ,  Vincent Minville ,  Bernard Frances ,  Francois Labaste ,  Claire Vinel

IPC分类号： A61K38/22 ,  A61K31/015 ,  A61K31/02 ,  A61K31/08 ,  A61K33/00 ,  A61P23/00 ,  A61P25/28

CPC分类号： A61K38/22 ,  A61K31/015 ,  A61K31/02 ,  A61K31/08 ,  A61K33/00 ,  A61P23/00 ,  A61P25/28

摘要： The present invention relates to methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction. In particular, the present invention relates to a method of treating post-operative cognitive dysfunction in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an APJ receptor agonist.

公开(公告)号：US20240207200A1

公开(公告)日：2024-06-27

申请号：US18555329

申请日：2022-04-12

申请人： DSM IP Assets B.V.

发明人： Maik KINDERMANN ,  Ulla LETINOIS ,  Luis Fernando MONTEIRO TAMASSIA ,  René Tobias STEMMLER ,  Nicola WALKER

IPC分类号： A61K31/045 ,  A23K20/105 ,  A23K50/10 ,  A61K9/00 ,  A61K31/015 ,  A61P1/14

CPC分类号： A61K31/045 ,  A23K20/105 ,  A23K50/10 ,  A61K9/0056 ,  A61K31/015 ,  A61P1/14

摘要： The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of limonene and propanediol mononitrate to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.

公开(公告)号：US20240165057A1

公开(公告)日：2024-05-23

申请号：US18383606

申请日：2023-10-25

申请人： Neohack Life Sciences LLC

发明人： Dale G. Brown ,  Ira D. Hill

IPC分类号： A61K31/16 ,  A61K31/015 ,  A61K31/045 ,  A61K31/164 ,  A61P23/02

CPC分类号： A61K31/16 ,  A61K31/015 ,  A61K31/045 ,  A61K31/164 ,  A61P23/02

摘要： In one aspect, this invention relates to a method for treating pain and subsequent resulting conditions. In yet another aspect, this invention relates to formulating agents to rapidly reverse painful conditions.

公开(公告)号：US11975036B2

公开(公告)日：2024-05-07

申请号：US18299784

申请日：2023-04-13

申请人： Ecofibre USA Inc. ,  The University of Newcastle

发明人： Alexandra M. Capano ,  Pradeep Singh Tanwar ,  Alex Nance

IPC分类号： A61K36/00 ,  A61K31/01 ,  A61K31/015 ,  A61K31/045 ,  A61K31/05 ,  A61K31/198 ,  A61K31/216 ,  A61K31/282 ,  A61K31/337 ,  A61K31/352 ,  A61K31/355 ,  A61K31/395 ,  A61K31/4745 ,  A61K31/513 ,  A61K31/519 ,  A61K31/675 ,  A61K31/704 ,  A61K31/7048 ,  A61K31/7068 ,  A61K33/243 ,  A61K36/185 ,  A61K39/395 ,  A61P35/00

CPC分类号： A61K36/185 ,  A61K31/01 ,  A61K31/015 ,  A61K31/045 ,  A61K31/05 ,  A61K31/198 ,  A61K31/216 ,  A61K31/282 ,  A61K31/337 ,  A61K31/352 ,  A61K31/355 ,  A61K31/4745 ,  A61K31/513 ,  A61K31/519 ,  A61K31/5545 ,  A61K31/675 ,  A61K31/704 ,  A61K31/7048 ,  A61K31/7068 ,  A61K33/243 ,  A61K39/3955 ,  A61P35/00

摘要： Methods for treating ovarian cancer comprising: administering to a patient and effective amount of a cannabis extract comprising CBD wherein preferably the cannabis extract is administered via a mucosal formulation.

公开(公告)号：US20240130979A1

公开(公告)日：2024-04-25

申请号：US18046125

申请日：2022-10-12

申请人： EpiTop, Inc.

发明人： Byung Eui KIM ,  Donald Y. M. LEUNG

IPC分类号： A61K31/015 ,  A61K8/31 ,  A61P17/00 ,  A61P17/02 ,  A61Q19/08

CPC分类号： A61K31/015 ,  A61K8/31 ,  A61P17/00 ,  A61P17/02 ,  A61Q19/08

摘要： Provided are a composition and a method for preventing, treating, or ameliorating a skin disease or condition. In some cases, the method comprises administering to the subject in need thereof a therapeutically effective amount of a composition comprising at least about 10 v/v % of thujopsene. In some cases, the skin disease or condition comprises a skin inflammatory disease, an allergic disease, a skin wound, a skin aging-related condition, or particulate matter (PM2.5)-associated condition.